Chordate Medical Holding AB (publ) (CMH.ST)
Chordate Medical Holding AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Kista, SE. The stock last traded at $0.10, down 37.50% on the session, giving a market capitalisation of $269,962. Its beta of 1.51 implies it has historically moved more than the broad market.
Established in 2005 and based in Kista, Sweden, Chordate Medical Holding AB (publ) is a medical technology company. This firm concentrates on developing products and solutions for the treatment of chronic migraine and rhinitis. Its specialization lies within the ear-nose and throat (ENT) area, with its operations primarily conducted in Sweden.
Chordate Medical Holding AB (publ) is most often compared with the following Healthcare names: